UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 17, 2020

Accession Number:	0001437749-20-012545
Submission Type:	POS AM
CIK: 0001427925 Company Name: ACELRX PHARMACEUTICALS INC File Number: 333-237584